Guang Hu

2PUBLICATIONS
17CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 10, 2026
PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.

|May 07, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy.

Jiahao Liu, Xiaofei Jiao, Wei Mu

Pageof 1

Frequent Collaborators

2 joint publications

Li Zhu

2 joint publications

Yong Fang

1 joint publications

Jiahao Liu

1 joint publications

Xiaofei Jiao